Trump Officials Review Biden-Era Funding For Moderna Bird Flu Vaccine Contract

US health officials are reviewing a nearly $600 million contract awarded to Moderna for bird flu vaccines in the final days of the Biden administration. The evaluation is part of a broader effort to reassess spending on mRNA-based vaccines, a technology that powered Moderna’s Covid shot. Moderna’s planned late-stage vaccine trial may not proceed without the funding. Moderna is under pressure to replace declining Covid vaccine sales. Shares of Moderna fell as much as 4% on Thursday after the news.